DK3580567T3 - I vitro-fremgangsmåde til diagnose af lungkræft - Google Patents
I vitro-fremgangsmåde til diagnose af lungkræft Download PDFInfo
- Publication number
- DK3580567T3 DK3580567T3 DK18703784.1T DK18703784T DK3580567T3 DK 3580567 T3 DK3580567 T3 DK 3580567T3 DK 18703784 T DK18703784 T DK 18703784T DK 3580567 T3 DK3580567 T3 DK 3580567T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnosis
- lung cancer
- vitro procedure
- vitro
- procedure
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17382054.9A EP3361256A1 (en) | 2017-02-08 | 2017-02-08 | In vitro method for the diagnosis of lung cancer |
PCT/EP2018/053234 WO2018146232A1 (en) | 2017-02-08 | 2018-02-08 | In vitro method for the diagnosis of lung cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3580567T3 true DK3580567T3 (da) | 2021-07-12 |
Family
ID=58043996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK18703784.1T DK3580567T3 (da) | 2017-02-08 | 2018-02-08 | I vitro-fremgangsmåde til diagnose af lungkræft |
Country Status (11)
Country | Link |
---|---|
US (1) | US20200025765A1 (da) |
EP (2) | EP3361256A1 (da) |
CN (1) | CN110770584B (da) |
AU (1) | AU2018217372B2 (da) |
CA (1) | CA3052529A1 (da) |
DK (1) | DK3580567T3 (da) |
ES (1) | ES2880761T3 (da) |
HU (1) | HUE054864T2 (da) |
PL (1) | PL3580567T3 (da) |
PT (1) | PT3580567T (da) |
WO (1) | WO2018146232A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2023513470A (ja) | 2020-01-30 | 2023-03-31 | プログノミック インコーポレイテッド | 肺バイオマーカーおよびそれらの使用方法 |
CA3163498A1 (en) * | 2020-10-02 | 2022-04-07 | Board Of Regents, The University Of Texas System | Methods for the detection and treatment of lung cancer |
GB2607436A (en) * | 2021-03-31 | 2022-12-07 | Prognomiq Inc | Multi-omic assessment |
AU2022341187A1 (en) | 2021-09-13 | 2024-03-21 | PrognomIQ, Inc. | Enhanced detection and quantitation of biomolecules |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007501948A (ja) * | 2003-06-13 | 2007-02-01 | ユニバーシティー オブ ピッツバーグ | 免疫疾患、血液疾患および炎症性疾患のモニタリング |
EP2788478B1 (en) * | 2011-12-09 | 2017-08-23 | Institut Pasteur | Multiplex immuno screening assay |
AU2012358246B2 (en) * | 2011-12-21 | 2018-01-25 | Integrated Diagnostics, Inc. | Methods for diagnosis of lung cancer |
ES2670661T3 (es) * | 2012-03-29 | 2018-05-31 | Proyecto De Biomedicina Cima, S.L. | Nuevos marcadores moleculares de cáncer de pulmón |
-
2017
- 2017-02-08 EP EP17382054.9A patent/EP3361256A1/en not_active Withdrawn
-
2018
- 2018-02-08 DK DK18703784.1T patent/DK3580567T3/da active
- 2018-02-08 US US16/483,714 patent/US20200025765A1/en active Pending
- 2018-02-08 PT PT187037841T patent/PT3580567T/pt unknown
- 2018-02-08 PL PL18703784T patent/PL3580567T3/pl unknown
- 2018-02-08 HU HUE18703784A patent/HUE054864T2/hu unknown
- 2018-02-08 CN CN201880020205.2A patent/CN110770584B/zh active Active
- 2018-02-08 AU AU2018217372A patent/AU2018217372B2/en active Active
- 2018-02-08 CA CA3052529A patent/CA3052529A1/en active Pending
- 2018-02-08 EP EP18703784.1A patent/EP3580567B1/en active Active
- 2018-02-08 ES ES18703784T patent/ES2880761T3/es active Active
- 2018-02-08 WO PCT/EP2018/053234 patent/WO2018146232A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA3052529A1 (en) | 2018-08-16 |
WO2018146232A1 (en) | 2018-08-16 |
CN110770584B (zh) | 2023-06-13 |
AU2018217372B2 (en) | 2024-01-25 |
US20200025765A1 (en) | 2020-01-23 |
EP3580567B1 (en) | 2021-04-07 |
PL3580567T3 (pl) | 2021-12-06 |
PT3580567T (pt) | 2021-07-14 |
EP3361256A1 (en) | 2018-08-15 |
CN110770584A (zh) | 2020-02-07 |
AU2018217372A1 (en) | 2019-09-12 |
ES2880761T3 (es) | 2021-11-25 |
HUE054864T2 (hu) | 2021-10-28 |
EP3580567A1 (en) | 2019-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3189082T3 (da) | Anti-pd-l1-konjugater til behandling af tumorer | |
DK3697887T3 (da) | Perfusionsfremgangsmåder | |
DK3474841T3 (da) | Fremgangsmåder til behandling af ar+-brystkræft | |
BR112016030398A2 (pt) | Instrumento cirúrgico endoscópico | |
DK3151663T3 (da) | Ex vivo-organplejesystem | |
MA42238A (fr) | Procédés de diagnostic du cancer de la vessie | |
DK3166976T3 (da) | Anti-pd-l1-kombinationer til behandling af tumorer | |
DE112015002825A5 (de) | Nicht-invasive Stoffanalyse | |
DK3302502T3 (da) | Intrapulmonal administration af polynukleotid-agonister af toll-lignende receptor-9 til behandling af lungecancer | |
DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
DK3474804T3 (da) | Medicinsk forbinding | |
EP3307243A4 (en) | Diagnostic test for early stage cancer | |
DK3117030T3 (da) | Diagnosticering af sepsis | |
DK3123381T3 (da) | Sammensætninger og fremgangsmåder relateret til diagnose af prostatacancer | |
DK3467111T3 (da) | LNCRNAS til terapi og diagnose af hjertehypertrofi | |
DK3560937T3 (da) | Fremgangsmåder til fremstilling af 18f-mærkede psma-målrettede billeddannelsesmidler og diagnostiske fremgangsmåder dermed | |
HK1248803A1 (zh) | 用於肝癌的無創診斷的特異性生物標誌物組 | |
DK3580567T3 (da) | I vitro-fremgangsmåde til diagnose af lungkræft | |
DK3058374T3 (da) | Fremgangsmåde til diagnose af primær hyperaldosteronisme | |
DK3461806T3 (da) | Fremgangsmåde til fremstilling af alfa-hydroxymethionin-analoger ud fra sukker | |
DE112015000447A5 (de) | Positionierhilfe für chirurgische Eingriffe | |
DK3452795T3 (da) | Inspektionsfremgangsmåde | |
SG10201913528PA (en) | Methods of diagnosing cancer | |
DK3474803T3 (da) | Medicinsk forbinding | |
DK3592297T3 (da) | Vævsteknologistilladser |